Neoplasms by Site: all 208 studies
Page 2 of 3. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT07162883Phase 3
- A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsActive, not recruitingNCT07038369Phase 1
- Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLCNo longer availableNCT06841874
- A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)Active, not recruitingNCT06606847Phase 2
- Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) StudyActive, not recruitingNCT06494241
- Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLCActive, not recruitingNCT06376084
- Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without RelatlimabActive, not recruitingNCT06237920Phase 2
- Real World Registry for Use of the Ion Endoluminal SystemActive, not recruitingNCT06004440
- A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based ChemotherapyActive, not recruitingNCT05941897Phase 2
- Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological MalignanciesCompletedNCT05895994Early Phase 1
- CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBLCompletedNCT05716113Early Phase 1
- A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed GlioblastomaActive, not recruitingNCT05664243Phase 1/2
- Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm StudyActive, not recruitingNCT05602935Phase 2
- Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsActive, not recruitingNCT05462717Phase 1
- Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable MetastasesStatus unknownNCT05322486
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsTerminatedNCT05241873Phase 1
- (HARMONY) Study of BLU-701 in EGFR-mutant NSCLCTerminatedNCT05153408Phase 1
- EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCActive, not recruitingNCT05150236Phase 2
- Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised SpecimenCompletedNCT05113134Not applicable
- TheraSphere With Durvalumab and Tremelimumab for HCCActive, not recruitingNCT05063565Phase 2
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active, not recruitingNCT04964934Phase 3
- Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy NeedleStatus unknownNCT04880681Not applicable
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCTerminatedNCT04862780Phase 1
- Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian CancerActive, not recruitingNCT04807166Phase 2
- Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsCompletedNCT04774952Phase 1
- A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseActive, not recruitingNCT04711252Phase 3
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
- Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerActive, not recruitingNCT04597411Phase 1
- Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and MelanomaActive, not recruitingNCT04572451Phase 1
- Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian CancerStatus unknownNCT04566952Phase 2
- Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian CancerStatus unknownNCT04556071Phase 2
- Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsCompletedNCT04299880Phase 1
- Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in ChinaCompletedNCT04287335
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 1
- Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerWithdrawnNCT04225299Phase 3
- Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04124198Not applicable
- Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC PatientsCompletedNCT04080843Phase 2
- EndoPredict® Extended Endocrine Trial (EXET)TerminatedNCT04016935
- Renal Cell Carcinoma Microenvironment Discovery ProjectCompletedNCT04005183
- Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast CancerStatus unknownNCT03692689Phase 2
- Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsStatus unknownNCT03634982Phase 1
- Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback StrategiesCompletedNCT03569605Not applicable
- Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]CompletedNCT03555422Phase 3
- 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerTerminatedNCT03490838Phase 1
- ASPIRIN Trial BelgiumActive, not recruitingNCT03464305Phase 3
- Expanded Access Use of Tucatinib for HER2+ Metastatic Breast CancerNo longer availableNCT03424473
- A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCCompletedNCT03134872Phase 3
- Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)TerminatedNCT03053297
- A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibTerminatedNCT03008512Phase 2
- The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer PatientsWithdrawnNCT03003195Phase 2
- uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal CancerStatus unknownNCT02960724Phase 2
- International Lung Screen Trial (ILST)Active, not recruitingNCT02871856Not applicable
- A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBMCompletedNCT02766699Phase 1
- A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyCompletedNCT02578797Phase 1
- Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)CompletedNCT02503696
- Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract CancersTerminatedNCT02503631
- PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate CancerTerminatedNCT02483884Phase 1/2
- A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion CohortsActive, not recruitingNCT02266745Phase 2
- SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study IWithdrawnNCT02254915Phase 3
- Microbiome Test for the Detection of Colorectal Polyps and CancerCompletedNCT02141945
- A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and TherapyTerminatedNCT02111824Phase 1
- Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerStatus unknownNCT02049190Phase 1/2
- Low Rectal Cancer Study (MERCURY II)Status unknownNCT02005965
- Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) TrialStatus unknownNCT01995942
- SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)CompletedNCT01966289Phase 1
- Protection of Rectum From High Radiation Doses Using a SpacerTerminatedNCT01918605Not applicable
- Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCStatus unknownNCT01917279Phase 3
- Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate CancerCompletedNCT01875393Phase 3
- Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseCompletedNCT01819766
- A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)WithdrawnNCT01799499Not applicable
- Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable CholangiocarcinomaStatus unknownNCT01739465Phase 2/3
- Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid TumorsCompletedNCT01629758Phase 1
- Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerCompletedNCT01610869Phase 2
- Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation TestingCompletedNCT01600209
- Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung CancerCompletedNCT01594398Phase 1
- A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsCompletedNCT01576380Phase 2
- A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung CancerTerminatedNCT01574222Phase 1
- Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaStatus unknownNCT01556815Phase 2
- The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking AspirinStatus unknownNCT01549418Phase 4
- ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerCompletedNCT01472146Phase 2
- The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionStatus unknownNCT01427400Phase 4
- Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.CompletedNCT01398306
- An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal CancerCompletedNCT01397305Phase 1/2
- An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.CompletedNCT01386580Phase 1/2
- Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaCompletedNCT01339975
- Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.CompletedNCT01310894Phase 3
- Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNCT01294826Phase 1
- Drainage After Rectal Excision for Rectal CancerCompletedNCT01269567Phase 3
- Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesCompletedNCT01260168
- Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck CancerStatus unknownNCT01247246Phase 2
- Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsTerminatedNCT01215578Phase 2
- Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNCT01215565Phase 2
- Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer TumorsStatus unknownNCT01204801Phase 3
- Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid TumorsTerminatedNCT01081808Phase 1
- Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related FatigueCompletedNCT01043913Phase 2
- A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
- Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksStatus unknownNCT01037049Phase 2
- Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
- Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast CancerCompletedNCT00983684Phase 3
- Study Using WST11 in Patients With Localized Prostate CancerCompletedNCT00975429Phase 2